Yingyi Qin

机构：Second Military Medical University · ORCID：0000-0002-3340-3776

发表论文 89 篇 · 总被引 1941 次 · h-index 21

代表论文

• Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial (2024 · Nature Medicine · 被引 133)
• Surgical treatment of hilar cholangiocarcinoma: retrospective analysis (2023 · BJS Open · 被引 19)
• Transarterial chemoembolization plus atezolizumab and bevacizumab in patients with intermediate hepatocellular carcinoma: a single-arm, phase 2 trial (2025 · Signal Transduction and Targeted Therapy · 被引 14)
• Association of life’s essential 8 with prevalence and all-cause mortality of chronic kidney disease among US adults: Results from the National Health and Nutrition Examination Survey (2015–2018) (2024 · Journal of Translational Internal Medicine · 被引 10)
• The magnesium depletion score is associated with increased likelihood of kidney stone disease among female adults (2024 · Journal of Trace Elements in Medicine and Biology · 被引 9)
• High composite dietary antioxidant index is associated with reduced risk of kidney stones: a cross-sectional analysis of NHANES 2007-2020 (2024 · Nutrition Research · 被引 4)